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Abstract
SIRT1 plays crucial roles in glucose and lipid metabolism, and has various functions in different tissues including brain. The
brain-specific SIRT1 knockout mice display defects in somatotropic signaling, memory and synaptic plasticity. And the
female mice without SIRT1 in POMC neuron are more sensitive to diet-induced obesity. Here we created transgenic mice
overexpressing SIRT1 in striatum and hippocampus under the control of CaMKIIa promoter. These mice, especially females,
exhibited increased fat accumulation accompanied by significant upregulation of adipogenic genes in white adipose tissue.
Glucose tolerance of the mice was also impaired with decreased Glut4 mRNA levels in muscle. Moreover, the SIRT1
overexpressing mice showed decreased energy expenditure, and concomitantly mitochondria-related genes were
decreased in muscle. In addition, these mice showed unusual spontaneous physical activity pattern, decreased activity in
open field and rotarod performance. Further studies demonstrated that SIRT1 deacetylated IRS-2, and upregulated
phosphorylation level of IRS-2 and ERK1/2 in striatum. Meanwhile, the neurotransmitter signaling in striatum and the
expression of endocrine hormones in hypothalamus and serum T3, T4 levels were altered. Taken together, our findings
demonstrate that SIRT1 in forebrain regulates lipid/glucose metabolism and motor function.
Citation: Wu D, Qiu Y, Gao X, Yuan X-B, Zhai Q (2011) Overexpression of SIRT1 in Mouse Forebrain Impairs Lipid/Glucose Metabolism and Motor Function. PLoS
ONE 6(6): e21759. doi:10.1371/journal.pone.0021759
Editor: Vincent Laudet, Ecole Normale Supe ´rieure de Lyon, France
Received February 2, 2011; Accepted June 6, 2011; Published June 30, 2011
Copyright:  2011 Wu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by grants from the National Natural Science Foundation of China (30825009, 30970619, 31030022 and 81021002), the
National Basic Research Program of China (973 Program, 2009CB918403, 2007CB914501 and 2006CB503900), the Chinese Academy of Sciences (KSCX1-YW-02),
the Director Foundation of Institute for Nutritional Sciences (20090101), and the SA-SIBS Scholarship Program. The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: qwzhai@sibs.ac.cn
Introduction
Obesity is becoming a worldwide prevalent disease in recent
years. Various diseases including diabetes, hepatic steatosis and
atherosclerosis are associated with dysregulation of lipid metabo-
lism. SIRT1, a NAD-dependant deacetylase, has been reported as
a key regulator of energy homeostasis to be involved in lipid and
glucose metabolism [1,2,3]. SIRT1 has been reported to attenuate
adipogenesis and promote fat mobilization in adipocytes [4,5].
SIRT1 liver-specific knockout mice showed better glucose
tolerance and less fat accumulation in white adipose tissue
(WAT) and liver than wild type when fed high-fat diet [6].
Deletion of SIRT1 in hepatocytes impaired PPARa signaling and
decreased fatty acid b-oxidation [7]. SIRT1 induced hepatic
glucose output through deacetylating PGC-1a in an NAD+-
dependent manner [8]. Furthermore, our previous study showed
that SIRT1 and resveratrol improved insulin sensitivity by
repressing PTP1B transcription in hepatocytes or C2C12
myotubes [9]. SIRT1 also deacetylated PGC-1a and upregulated
mitochondrial genes and fatty acid oxidation genes in skeletal
muscle cells [10]. Moreover, pancreatic b cell-specific SIRT1
overexpressing transgenic mice exhibited improved glucose
tolerance and enhanced insulin secretion in response to glucose
stimulation [11]. And further study showed that SIRT1 repressed
the uncoupling protein 2 transcription and positively regulated
insulin secretion in pancreatic b cells [12]. Oral administration
with SIRT1 activator resveratrol or SRT1720 in high-calorie-diet
fed mice or diabetic mice improved hepatic, adipose and systemic
insulin sensitivity, prevented the development of fatty liver and/or
increased mitochondrial activity in the brown adipose tissue (BAT)
and muscle [13,14,15]. All these studies demonstrate that SIRT1
plays crucial roles in lipid and glucose metabolism in peripheral
tissues.
SIRT1 also plays important roles in central nervous system [16].
Overexpression of SIRT1 in APPswe/PSEN1dE9 mice alleviated
brain pathology and behavioral deficits, and SIRT1 brain-specific
knockout in the mice aggravated the symptoms [17]. Overexpres-
sion of SIRT1 in the CA1 region of p25 transgenic mice by
injection of lentivirus also protected against neurodegeneration
[18]. In addition, inhibition of SIRT1 in neurons increased IRS-2
acetylation and decreased phosphorylation of IRS-2 and ERK1/2
to protect neurons against oxidative stress [19]. Recently, brain-
specific SIRT1 knockout mice showed defects in somatotropic
signaling when fed ad libitum and defects in endocrine and
behavioral responses under calorie restriction condition [20].
Knockout of SIRT1 in pro-opiomelanocortin (POMC) neurons
caused reduced energy expenditure in mice and then hypersen-
sitivity to diet-induced obesity [21]. The mice overexpressing
SIRT1 driven by prion (PrP) promoter showed enhanced neural
activity in hypothalamic nuclei, higher body temperature and
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SIRT1 played essential roles in memory and synaptic plasticity
[23,24]. Despite the huge progress in the understanding of
functional importance and molecular mechanisms of SIRT1, the
functions of SIRT1 in specific brain regions need more intensive
study.
Given the important roles of SIRT1 in central nervous system,
we developed a SIRT1 transgenic mouse model under the control
of CaMKIIa promoter and investigated the role of SIRT1 in
forebrain. We show that the transgenic mice exhibited increased
fat accumulation, impaired glucose tolerance and motor function.
And these changes were coupled with altered IRS-2 and
neurotransmitter signaling in striatum and impaired expression
of genes regulating lipid and glucose metabolism in various tissues.
Altogether, our results demonstrate that SIRT1 in forebrain is
very important for regulating lipid/glucose metabolism and motor
function.
Results
Generation of bitransgenic mice with forebrain-specific
SIRT1 overexpression
To further investigate the role of neuronal SIRT1, we first made
the TRE-SIRT1 construct, which contains a tTA-responsive
promoter followed by SIRT1 coding sequence with an N-terminal
myc tag, to generate TRE-SIRT1 single transgenic mice (Fig. 1A).
T h e nt h es i n g l et r a n s g e n i cm i c ew e r ec r o s s e dw i t hC a M K I I a-tTA
mice, which specifically drive tTA expression in forebrain [25], to
create CaMKIIa-tTA/TRE-SIRT1 bitransgenic mice (Fig. 1B).
WesternblotanalysisrevealedthatSIRT1proteinlevelwasincreased
to 2.3-fold in striatum and 1.3-fold in hippocampus, but no obvious
change in cerebral cortex of bitransgenic mice when compared with
their littermate controls (Fig. 1C and D). Similar SIRT1 protein levels
between bitransgenic mice and their littermates were detected in
WAT, BAT, liver, pancreas, muscle and hypothalamus (Fig. 1E–J).
These results demonstrate that the bitransgenic mice exhibit a
forebrain-specific SIRT1 overexpression.
Fat accumulation increases in the bitransgenic mice
To explore the effect of forebrain SIRT1 on metabolism, we
examined the body weight, fat and lean content of the bitransgenic
mice. Interestingly, female bitransgenic mice showed progressive
increases in body weight compared with littermate controls when
measured at the age of 13, 18 or 22 weeks (Fig. 2A). Measurement
of fat and lean mass using NMR showed that the fat mass and fat
content of female bitransgenic mice was increased by two to three
folds compared with littermate controls (Fig. 2B and C), while the
lean content was slightly reduced (Fig. 2D). Therefore the
increased body weight was mainly due to the dramatic increase
of fat accumulation. Furthermore, we found that there was a
decrease in fasting triglyceride level of female bitransgenic mice,
while no significant changes were observed in the levels of total
cholesterol, low-density lipoprotein cholesterol and high-density
lipoprotein cholesterol (Fig. 2E).
PPARc is a master regulator of adipogenesis [26], so we
analyzed the mRNA levels of Pparg in WAT, BAT and liver.
Pparg1 and 2 were both increased by two folds in WAT of female
bitransgenic mice. Consistent with this result, the mRNA levels of
PPARc target genes including fatty acid binding protein 4 (Fabp4/
Ap2), fatty acid transporter Cd36 and lipoprotein lipase (Lpl) were
all increased markedly. And the mRNA levels of adipogenic gene
Cebpa, de novo lipogenic genes Acca and Fasn, cholesterol synthesis
gene Srebf1 and esterification genes Gpam and Dgat1 were not
changed in WAT of female bitransgenic mice (Fig. 2F). Mean-
while, only significant increase of Cd36 was observed in liver
(Fig. 2H), and no obvious difference was detected in BAT (Fig. 2G).
Collectively, these results suggest that the upregulation of Pparg
and its downstream genes in WAT probably accounts for the
increase of fat mass in the female bitransgenic mice.
We also examined the body composition of male bitransgenic
mice. They had similar body weight compared with their
littermate controls (Fig. S1A). The fat mass and fat content of
male bitransgenic mice also significantly increased as females (Fig.
S1B and C), and the lean content was also slightly decreased when
measured at the age of 18 or 22 weeks old (Fig. S1D). There were
no significant changes of fasting triglyceride, total cholesterol, low-
density lipoprotein cholesterol and high-density lipoprotein
cholesterol levels in male bitransgenic mice (Fig. S1E). Taken
together, these results show that forebrain-specific SIRT1
overexpression leads to the significant increase of fat content and
the slight decrease of lean mass in both male and female
bitransgenic mice.
Forebrain-specific SIRT1 overexpression decreases
glucose tolerance
Obesity is usually associated with impaired glucose tolerance
and insulin resistance [27], so we examined glucose tolerance and
Figure 1. Generation of transgenic mice with forebrain-specific
SIRT1 overexpression. (A) Schematic representation of the TRE-SIRT1
construct. (B) Genetic strategy to generate CaMKIIa-tTA/TRE-SIRT1
bitransgenic mice. (C) SIRT1 protein levels markedly increased in the
striatum of bitransgenic mice (biT) compared with littermate controls
(Con). Expression of SIRT1 in cerebral cortex (Cor.), striatum (Str.) and
hippocampus (Hip.) were monitored by western blot using myc-tag or
SIRT1 antibody. GAPDH was measured as loading control. (D)
Quantification of the relative SIRT1 protein levels corresponding to
(C). Except indicated, in this and all other figures, error bars represent
SD. n=4 pairs. * P,0.05, ** P,0.01 versus littermate controls. (E–J)
SIRT1 protein levels were not changed in white adipose tissue (WAT) (E),
brown adipose tissue (BAT) (F), liver (G), pancreas (H), muscle (I) and
hypothalamus (J) as detected by western blot.
doi:10.1371/journal.pone.0021759.g001
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bitransgenic mice displayed impaired glucose tolerance when
compared with their littermate controls (Figs. 3A, 3B,S 2 A, and
S2B). Meanwhile, insulin tolerance test revealed that insulin
sensitivity was not significantly altered in both female and male
bitransgenic mice (Figs. 3C, 3D,S 2 C and S2D). In addition, the
fasting serum insulin levels were not changed the bitransgenic mice
(Figs. 3E and S2E). The two key enzymes of gluconeogenesis,
G6pase and Pepck, remained unchanged in liver (Fig. 3G), while
the Glut4 mRNA level was decreased about 50% in gastrocnemius
and quadriceps, which might reduce the glucose uptake in muscle
(Fig. 3F). These results demonstrate that the forebrain-specific
SIRT1 overexpression leads to impaired glucose tolerance, which
might partially due to the decreased Glut4 levels in muscle.
Forebrain-specific SIRT1 overexpression decreases
energy expenditure
We further investigated the effects of forebrain-specific SIRT1
overexpression on food intake, physical activity, oxygen consump-
tion and body temperature. Female bitransgenic mice showed
similar food intake as littermate controls, and male bitransgenic
mice showed significantly decreased food intake when monitored
from 13 to 18 weeks of age (Figs. 4A and S3A). Using a
comprehensive laboratory animal monitoring system, female
bitransgenic mice at four months of age showed similar daily
physical activities but significantly reduced physical activities (by
about 40%) between 8pm and 9pm and have a different
spontaneous physical activity pattern at night (Fig. 4B). And the
female bitransgenic mice displayed significantly lower oxygen
consumption than their littermate controls at 12 months of age
(Fig. 4C). In addition, the rectal temperature of the female
bitransgenic mice were significantly decreased (Fig. 4D). Mean-
while, physical activity level, oxygen consumption and the rectal
temperature of the male bitransgenic mice were similar as their
littermate controls (Fig. S3B, C and D). These results demonstrate
that the forebrain-specific SIRT1 overexpression leads to
decreased energy expenditure which might contribute to the
increased fat accumulation.
BAT and muscle are the most important organs responsible for
regulating thermogenesis [28], so we examined the mitochondria-
related genes in BAT, gastrocnemius and quadriceps. The genes
including Pgc1a, Mfn2, Ucp2 and Pdk4 in gastrocnemius were
markedly downregulated (Fig. 4F). The same downregulation was
also observed with Ucp2 in quadriceps (Fig. 4G). However, these
genes did not significantly change in BAT (Fig. 4E). The
downregulation of mitochondria-related genes in gastrocnemius
and quadriceps muscles might contribute to the diminished
oxygen consumption and energy expenditure.
Forebrain-specific SIRT1 overexpression impairs motor
function
Because striatum has a fundamental role in the control of motor
activity [29], we evaluated the motor behavioral responses of the
bitransgenic mice by open field test. Female bitransgenic mice
crossed a lower number of squares than their littermate controls,
while no significant change was observed in male bitransgenic
mice (Figs. 5A and S4A). The number of rearings for both genders
was similar to that of respective littermate controls (Figs. 5B and
S4B). These data indicate that forebrain-specific SIRT1 overex-
pression in female mice impairs exploratory activity. When
measured with rotarod test, female bitransgenic mice showed
much shorter latency on rotarod than their littermate controls
when the rotating speed reached 15 rpm on both the first and
second days (Fig. 5C and D). The latency of male bitransgenic
mice was also shorter than that of the control mice on both the first
and second days (Fig. S4C and D). All these data indicate that
Figure 2. Female bitransgenic mice exhibit increased fat accumulation accompanied by increased expression of adipogenic genes
in WAT. (A) Body weights of female bitransgenic mice increased when compared with littermate controls (n=7–11 for each group). (B–C) Fat mass
and fat content markedly increased in female bitransgenic mice compared with littermate controls (n=7–11 for each group). (D) Lean content
decreased in female bitransgenic mice compared with littermate controls (n=7–11 for each group). (E) Fasting serum levels of total triglyceride (TG),
cholesterol (TC), high-density lipoprotein cholesterol (HDLc), low-density lipoprotein cholesterol (LDLc) were measured at 3 months of age (n=6–7
for each group). (F) The expression of some adipogenic genes increased in WAT of female bitransgenic mice. (G) The expression of the indicated
adipogenic genes was not significantly changed in BAT of female bitransgenic mice. (H) The expression of the indicated adipogenic genes except
Cd36 was not changed in liver of female bitransgenic mice. * P,0.05, ** P,0.01 versus littermate controls.
doi:10.1371/journal.pone.0021759.g002
Forebrain SIRT1 and Metabolism
PLoS ONE | www.plosone.org 3 June 2011 | Volume 6 | Issue 6 | e21759Figure 3. Forebrain-specific SIRT1 overexpression impairs glucose tolerance in female mice. (A) Glucose tolerance was impaired in 5-
month-old female bitransgenic mice as determined by glucose tolerance test (n=7 for each group). ** P,0.01 versus littermate controls by two-way
ANOVA. Two-way ANOVA indicated that the curves for glucose tolerance were significantly different, P=0.0199. (B) Forebrain-specific SIRT1
overexpression in females significantly increased the area under the curve (AUC) of the glucose tolerance test in (A). (C) 5-month-old female
bitransgenic mice have similar insulin sensitivity as littermate controls when determined by insulin tolerance test (n=6 for each group). (D) The AUC
of the insulin tolerance test did not change in female bitransgenic mice. (E) Fasting serum insulin was measured at 3 months of age (n=6–7 for each
group). (F) The Glut4 mRNA levels in WAT, quadriceps (Quad) and gastrocnemius (Gast) muscle. (G) The G6pase and Pepck mRNA levels were
comparable between bitransgenic mice and littermate controls. * P,0.05, ** P,0.01 versus littermate controls.
doi:10.1371/journal.pone.0021759.g003
Figure 4. Female bitransgenic mice show abnormal spontaneous physical activity and decreased oxygen consumption and body
temperature. (A) Food intake was similar between female bitransgenic mice and their littermate controls (n=11 for each group). (B) Female
bitransgenic mice had different physical activity pattern but similar daily physical activities when measured at 16 weeks of age through a 12-hour light/
darkcycle usinga comprehensive laboratoryanimalmonitoring system(n=7 foreach group). Physicalactivity was presented as mean 6 SEM. Theslope
coefficients of best-fit linear regression curves for the night activity were markedly different between bitransgenic mice and their littermate controls
(shown as insert). (C) Oxygen consumption decreased in female bitransgenic mice at 12 months of age, n=7 for each group at the age of 4-month old,
n=5foreachgroupattheageof12-monthold.(D)Bodytemperaturedecreasedinfemalebitransgenicmice(n=7foreachgroup).(E)Theexpressionof
the indicated mitochondrial genes did not change in the BAT of female bitransgenic mice when measured by real-time PCR. (F) The expression of some
mitochondrial genes decreased in the gastrocnemius of female bitransgenic mice compared with littermate controls. (G) The expression of Ucp2
decreased in the quadriceps of female bitransgenic mice compared with littermate controls. * P,0.05, ** P,0.01 versus littermate controls.
doi:10.1371/journal.pone.0021759.g004
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motor function. Meanwhile, improved performance was observed
for both genotypes and both genders in the second day, which
suggest that motor learning is normal in bitransgenic mice (Figs. 5D
and S4D).
SIRT1 overexpression alters IRS-2 and neurotransmitter
signaling in striatum and expression of endocrine
hormones in hypothalamus
It has been reported that knockdown of SIRT1 in cultured
cortical neurons increased acetylation of IRS-2, and reduced
phosphorylation of IRS-2 and ERK1/2 [19]. So we further
examined these signaling events in forebrain of the female
bitransgenic mice. Consistent with the previous in vitro results,
SIRT1 was coimmunoprecipitated with IRS-2 in cerebral cortex,
striatum and hippocampus (Fig. 6A). The SIRT1 overexpression in
striatum decreased acetylation of IRS-2, and increased phosphor-
ylation of IRS-2 and ERK1/2 (Fig. 6A). ERK1/2 signaling is
essential for neuronal transcriptional regulation, and plays
important roles in glutamate and dopamine signaling in striatum
[30]. So we detected the expression of genes related to
neurotransmitter signaling in striatum. Both NMDA receptor
Grin2a and dopa decarboxylase Ddc increased in female
bitransgenic mice. In addition, the mRNA level of cannabinoid
receptor Cnr1, which regulates the release of neurotransmitters
from axon terminals [31], was significantly decreased in female
bitransgenic mice (Fig. 6B). Meanwhile, the mRNA level of SIRT1
in bitransgenic mice was markedly increased in striatum compared
with their littermate controls.
PGC1a is an important substrate of SIRT1, and its deficiency in
striatum is associated with certain behavioral abnormalities [8,32].
In female bitransgenic mice, the mRNA levels of Pgc1a and its
related genes in striatum were not changed when compared with
their littermate controls (Fig. S6C).
It has been reported that SIRT1 improved insulin sensitivity by
repressing PTP1B in C2C12 myotubes [9], and neuronal PTP1B
regulated body weight, adiposity and leptin action in hypothal-
amus [33]. So we examined the mRNA and protein levels of
PTP1B in the striatum and hypothalamus of female bitransgenic
mice, and found they were not significantly changed (Fig. S5A–C).
Meanwhile, the WAT leptin mRNA levels and fed serum leptin
levels were elevated in female bitransgenic mice (Fig. S5D),
suggesting that leptin might be involved in the forebrain SIRT1
function of metabolic regulation. Furthermore, leptin has been
shown to stimulate Socs3 expression [34]. So we checked the
mRNA levels of Lepr and Socs3 in the striatum and
hypothalamus of female bitransgenic mice, and found that they
were not altered (Fig. S5E). In addition, it has been shown that
leptin regulated the expression of MCH, POMC, AgRP, NPY
and CART in hypothalamus [35]. We found that the mRNA
Figure 5. Female bitransgenic mice show decreased motor
behavior by open field and rotarod tests. (A) Female bitransgenic
mice crossed fewer squares in the open field test than littermate
controls (n=9–14 for each group). * P,0.05, ** P,0.01 versus littermate
controls. Two-way ANOVA showed significant difference between
groups, P,0.0001. (B) Female bitransgenic mice had similar number
of rearings in the open field test (n=9–14 for each group). (C) Rotarod
performance on the first day was significantly decreased in female
bitransgenic mice (n=11 for each group). Mice were placed on a rod
rotating for 60 seconds at the indicated speeds, and the latency to fall
off from the rotarod was measured. * P,0.05, ** P,0.01 versus
littermate controls by two-way ANOVA. Two-way ANOVA showed
significant difference between curves, P=0.0156. (D) Rotarod perfor-
mance on the second day was significantly decreased in female
bitransgenic mice (n=11 for each group). * P,0.05, ** P,0.01 versus
littermate controls by two-way ANOVA. Two-way ANOVA showed
significant difference between curves, P=0.0113.
doi:10.1371/journal.pone.0021759.g005
Figure 6. SIRT1 overexpression activates IRS-2 and ERK1/2 in
striatum, and alters gene expression in striatum and hypo-
thalamus. (A) Representative blots showed the effect of SIRT1 on
acetylation of IRS-2 and phosphorylation of IRS-2 and ERK1/2 in the
cerebral cortex, striatum and hippocampus of 3-month old female mice.
The indicated tissues were lysed and immunoprecipitated with anti-IRS-
2 and blotted with anti-acetylated-lysine (AcK), phosphotyrosine (PY),
IRS-2 or SIRT1 antibody respectively. Lysates were also probed with IRS-
2, SIRT1, phospho-ERK1/2 (p-ERK1/2) or ERK1/2 antibody respectively.
(B) The expression of some genes involved in neurotransmitter
signaling were altered in the striatum of female bitransgenic mice
(n=3 for each group). (C) Hypothalamic mRNA levels of some
endocrine hormones in female bitransgenic mice were decreased when
detected by real-time PCR (n=6–7 for each group). * P,0.05 versus
littermate controls. (D) Serum T3 and T4 levels in female bitransgenic
mice were decreased when detected by ELISA (n=10–11 for each
group). * P,0.05 versus littermate controls.
doi:10.1371/journal.pone.0021759.g006
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Cartpt were not changed in the hypothalamus of female
bitransgenic mice (Fig. S5F). These results are consistent with
the normal food intake in the female bitransgenic mice (Fig. 4A).
There were also normal SIRT1 mRNA levels in the hypothal-
amus of female bitransgenic mice, which is consistent with the
normal SIRT1 protein levels (Fig. 1J). However, the mRNA
levels of endocrine hormones including somatostatin, gonadotro-
pin-releasing hormone and thyrotropin-releasing hormone were
significantly decreased in the hypothalamus (Fig. 6C). Because
hypothalamic somatostatin inhibits the release of growth
hormone from the pituitary [36] and growth hormone regulates
body length [37], we compared the snout-anus length between
bitransgenic mice and controls. As shown in Fig. S6B,n o
significant difference was observed. The serum levels of thyroid
hormones triiodothyronine (T3) and tetraiodothyronine (T4) in
female and male bitransgenic mice were decreased compared to
controls (Figs. 6D and S6C). The decreased expression of
thyrotropin-releasing hormone in hypothalamus and reduced
serum T3 and T4 levels might contribute to the changes in lipid
and glucose metabolism of the bitransgenic mice.
Discussion
In this study, we created CaMKIIa-tTA/TRE-SIRT1 bitrans-
genic mice which mainly overexpressed SIRT1 in striatum. The
bitransgenic mice showed increased fat content, impaired glucose
tolerance and decreased motor function. Further studies suggest
that these phenotypes in female bitransgenic mice result from the
altered IRS-2 and neurotransmitter signaling in striatum and
impaired expression of genes regulating lipid and glucose
metabolism in various tissues.
Our previous study showed that increased expression of SIRT1
can directly improve insulin sensitivity under insulin-resistant
conditions in C2C12 myotubes [9]. The SIRT1 transgenic mice
by knocking in SIRT1 cDNA into the b-actin locus became leaner,
and displayed decreased fasting blood insulin and glucose levels
and increased glucose tolerance, which was postulated due to
SIRT1 overexpression in adipose tissue [38]. BAC-based trans-
genic mice overexpressing SIRT1 in various tissues exhibited
normal fat mass and protected against high-fat diet-induced
impaired glucose tolerance and hepatic steatosis due to decreased
hepatic glucose production [39,40]. These studies demonstrate
that SIRT1 improves glucose and insulin tolerance in peripheral
cells and tissues. SIRT1 POMC neuron-specific knockout female
mice got more fat mass when fed on high-calorie diet [21].
Knockout of SIRT1 in Agrp neurons led to lower body weight,
lean mass and fat mass in female mice [41]. Interestingly, our
female bitransgenic mice overexpressing SIRT1 in forebrain,
showed significant increase of fat mass (Fig. 2B and C).
Furthermore, SIRT1 null mice displayed better glucose tolerance
and hypermetabolic [12,42]. SIRT1 brain-specific knockout mice
displayed a reduction in fasting blood glucose level [20].
Consistently, our forebrain overexpressing SIRT1 mice showed
impaired glucose tolerance (Figs. 3A and S2A) and decreased
energy expenditure (Fig. 4C). In addition, we found that the
SIRT1 mRNA levels were upregulated by fasting in hypothalamus
and hippocampus, but not changed in striatum and other tested
brain regions (Fig. S7). All the above findings suggest that SIRT1
may have different effects on glucose and lipid metabolism in
different brain regions and peripheral tissues.
The male and female bitransgenic mice differed in the degree of
fat accumulation at the same age (Figs. 2 and S1). The gender
difference in the impairment of glucose tolerance might be related
with the difference in the development of excess adiposity. The
male mice even did not show obvious changes in open field and
rotarod performance compared to female mice (Figs. 5 and S4).
To investigate whether the overexpression levels of SIRT1 are
contributed to the more obvious phenotype in female bitransgenic
mice, we measured SIRT1 protein levels and found that the
overexpression levels of SIRT1 are similar between the females
and males in both striatum and hippocampus (data not shown).
Thus, the more obvious phenotype in female bitransgenic mice
should be mainly due to the gender difference, especially
difference in gender-related hormones. The female bitransgenic
mice with more fat accumulation might be related to the fact that
females have a higher percentage of body fat, and adipocytes from
female mice have increased lipogenic rates compared with those
from males [43]. Although both male and female bitransgenic
mice show similar alteration in T3 and T4 levels compared to
control mice (Figs. 6D and S6C), the function and regulation of
thyroid hormone depend on gender differently [44,45]. In
consistent with our observation, it has been reported that the
mice with specific deletion of SIRT1 in POMC neurons show
more pronounced changes of body weight in females than in males
[21]. Similarly, the female mice with deletion of SIRT1 in Agrp
neurons showed a more marked phenotype with reductions in fat
mass than males [41]. Taken together, these studies indicate that
the roles of SIRT1 in some distinct neurons may be significantly
affected by gender.
The striatum is a major forebrain nucleus that has been
proposed to play important roles in the development of motor
deficits of Parkinson’s disease and Huntington’s disease [46]. The
female bitransgenic mice with high expression of SIRT1 in
striatum showed similar daily physical activity but reduced
physical activity at the time point when normal mice reached
peak activity (Fig. 4B), which is similar to the phenotype of mice
treated with SIRT1 activator resveratrol [15]. It should be pointed
out that the female bitransgenic mice maintained similar activity
level throughout the nighttime without a peak of activity level as
observed in the control mice (Fig. 4B). Both the SIRT1 transgenic
mice by knocking in SIRT1 cDNA into the b-actin locus and the
male mice treated with resveratrol showed improved rotarod
performance [15,38]. The bitransgenic mice overexpressing
SIRT1 in forebrain showed impaired rotarod performance
(Figs. 5C, 5D,S 4 C and S4D). The male mice treated with
resveratrol or overexpressing SIRT1 under the control of rat
neuron-specific enolase promoter, and the male SIRT1 null mice
all exhibited normal activity during open field exploration
[15,23,47]. Here, the male bitransgenic mice also showed similar
behavior as their littermate controls in the open field test, but the
female bitransgenic mice showed decreased crossed squares (Figs.
S4A and 5A). These results show that SIRT1 in striatum or other
tissues may regulate motor function, but the details need further
investigation.
It has been shown that neuronal PTP1B regulated body weight,
adiposity and leptin action [33], however the PTP1B expression
was not altered in the striatum and hypothalamus of female
bitransgenic mice (Fig. S5A–C). The WAT leptin mRNA levels
and fed serum leptin levels were significantly increased in female
bitransgenic mice (Fig. S5D). Meanwhile, the mRNA levels of
Lepr and Socs3 in the striatum and hypothalamus, and the leptin-
regulated neuropeptides including Pmch, Pomc, Agrp, Npy and
Cartpt in hypothalamus were not altered in female bitransgenic
mice (Fig. S5E). Combined with the normal food intake in the
female bitransgenic mice (Fig. 4A), these data suggest that mild
leptin resistant might be involved in the forebrain SIRT1 function
of metabolic regulation. SIRT1 regulates systemic metabolism by
Forebrain SIRT1 and Metabolism
PLoS ONE | www.plosone.org 6 June 2011 | Volume 6 | Issue 6 | e21759deacetylating various proteins including PGC1a and IRS-2 [3].
We found that the expression levels of Pgc1a and its related genes
did not alter in striatum (Fig. S6A), which suggests PGC1a is not a
key substrate of SIRT1 in striatum. It has been reported that
SIRT1 deacetylated IRS-2 in cultured cortical neurons, and the
inhibition of SIRT1 impaired ERK1/2 activation [19]. Here we
found that SIRT1 deacetylated IRS-2 and activated ERK1/2
signaling in striatum of female bitransgenic mice (Fig. 6A). ERK1-
null mice were hyperactive in multiple motility tests including
open field test [48,49]. Therefore, we speculated that the increased
phosphorylation of ERK1/2 might represent the underlying
mechanisms of impaired motor function in open field and rotarod
test for the bitransgenic mice. ERK1/2 mediated the NMDA,
dopamine and endocannabinoid signalings, which have critical
roles in the control of movement [46,50,51,52]. So the increased
expression of NMDA receptor Grin2a and dopa decarboxylase
Ddc, and the decreased expression of endocannabinoid receptor
Cnr1 in striatum might also contribute to the motor defects of the
bitransgenic mice (Fig. 6B). However, the precise mechanisms by
which SIRT1 regulate motor activity need to be further
investigated. On the other hand, hypothalamus is very important
in regulating metabolism. We detected the mRNA levels of
endocrine hormones in hypothalamus, and found that the
expression of somatostatin, gonadotropin-releasing hormone and
thyrotropin-releasing hormone were changed in female bitrans-
genic mice (Fig. 6C). And the thyroid hormones T3 and T4
concentrations decreased in serum of bitransgenic mice (Figs. 6D
and S6C). It was reported that thyroid hormones regulated
adipocyte differentiation [53] and the transcription of genes such
as UCPs [54]. Consistent with these reports, we found that some
important adipogenic genes were markedly upregulated in WAT
(Fig. 2F) and UCPs were decreased in muscle (Fig. 4G and H). It
has been reported that hypothyroid mice showed decreased
rotarod performance [55]. The rotarod performance of bitrans-
genic mice also decreased in our study (Fig. 5C and D). So the
decreased hypothalamic thyrotropin-releasing hormone level and
serum T3 and T4 levels might contribute to both the impaired
lipid/glucose metabolism and the impaired motor function. The
changes in hypothalamus may result from the alteration of the
neurotransmitter signaling in striatum through striatal-hypotha-
lamic circuitry [56]. These alterations in striatum and hypothal-
amus suggest a possible mechanism underlying the roles of
forebrain SIRT1 in lipid/glucose metabolism and motor function.
However, whether IRS-2 acetylation and tyrosine phosphoryla-
tion, ERK1/2 phosphorylation in striatum are essential for the
impaired lipid/glucose metabolism and motor function in female
bitransgenic mice needs to be studied in the future. Generation of
mouse strains with forebrain specific point mutation of IRS-2
acetylation site or tyrosine phosphorylation site and forebrain
specific deletion of ERK1/2 should be very helpful to elucidate the
underlying mechanisms.
In conclusion, our study demonstrates overexpressing SIRT1 in
mouse forebrain causes increased fat accumulation, impaired
glucose tolerance and motor defects. These findings show that
SIRT1 in different tissues may exert different impacts on lipid/
glucose metabolism and motor function, which provide novel
insights into the complexity and diversity of SIRT1 functions.
Materials and Methods
Generation of forebrain transgenic Mice
The generation of the TRE-SIRT1 mice using gene-targeting
strategy was carried out at the Model Animal Research Center of
Nanjing University (MARC). Briefly, the mouse SIRT1 cDNA
from pBabe-SIRT1 plasmid (kindly provided by Dr. Shin-ichiro
Imai, Washington University School of Medicine) was subcloned into
pCMV-Myc vector (Clontech). And then the myc-SIRT1 fragment
was introduced into pTRE2 vector (Clontech). After digested by
ApaLI and XbaI, the fragment containing the tTA-responsive
promoter followed by myc-SIRT1 was injected into mouse fertilized
oocytes derived from C57BL/66C B AF 1m i c et og e n e r a t eT R E -
SIRT1 transgenic mice. And then the TRE-SIRT1 transgenic mice
were backcrossed for at least three generations with C57BL/6 mice
obtained from Slaccas (Shanghai, China). The mice generated
through the crossing of CaMKIIa-tTA mice [25] and TRE-SIRT1
mice were referred as bitransgenic mice, which were identified by
PCR from their genomic DNA. The primers CAAAGGAGCA-
GATTAGTAAGCGG and TCCCCCTGAACCTGAAACATAA-
A were used to detect the exogenous SIRT1. The primers CGC-
TGTGGGGCATTTTACTTTAG and CATGTCCAGATCGA-
AATCGTC were used to detect tTA.
Animal care
All animal experiments were performed in accordance with
National Institutes of Health guidelines and with the approval of
the Institutional Animal Care and Use Committee of the Institute
for Nutritional Sciences. Mice were kept in specific pathogen-free
conditions maintained at 2263uC with a fixed 12-h light/dark
cycle (lights on at 6:30 a.m.) with ad libitum access to standard chow
and water in an institutional animal facility.
Phenotypic analysis
In all the experiments, gender-matched littermates including
CaMKIIa-tTA or TRE-SIRT1 single transgenic and wild type
mice were used as controls. Mice were weighed at the indicated
time points. The food intake was measured every 2 days from 13
weeks to 18 weeks of age. Rectal body temperatures of 8-month-
old mice were measured using microprobe thermometer (Physi-
temp Instruments) between 14:00 and 16:00. Total body fat and
lean mass were measured in conscious mice using a Minispec
Mq7.5 Analyzer (Bruker). Mice were anesthetized with sodium
pentobarbital, and then cerebral cortex, striatum, hippocampus,
hypothalamus, liver, white adipose tissue, brown adipose tissue
and muscle were quickly removed and snap-frozen in liquid
nitrogen and stored at 280uC for western blot, immunoprecip-
itation and real-time PCR. For fasting and refeeding experiments,
8-week-old C57BL/6J female mice were fed ad libitum, fasted for
24 h, or fasted for 24 h and refed for 24 h (5–7 mice for each
group). Then, animals were sacrificed, and the indicated brain
regions were removed and snap-frozen for real-time PCR. Snout-
anus length was measured with a micrometer on 12-week-old
anaesthetized mice. Blood samples were obtained fed or after a 20-
h fasting and stored at 280uC. Fed leptin level was measured
using an ELISA kit from R&D systems. Serum insulin level was
measured using a radioimmunoassay kit and T3, T4 levels were
measured using ELISA kits from Beijing Beifang Institute of
Biological Products. Triglyceride, total cholesterol, high-density
lipoprotein cholesterol and low-density lipoprotein cholesterol
levels in serum were determined using enzymatic assay kits from
Shanghai Shensuo Unf Medical Diagnostics Articles Company.
Glucose tolerance test and insulin tolerance test
Glucose and insulin tolerance tests were performed as
previously described [9]. Briefly, after fasting for 12 h or 6 h,
mice were injected intraperitoneally with either 2 g/kg of glucose
or 0.75 U/kg of human insulin (Lilly France S.A.S) respectively.
Tail blood glucose was measured before and 15, 30, 60 or 120 min
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system (TheraSense).
Oxygen consumption and physical activity
Oxygen consumption and physical activity were determined
with mice fed ad libitum using a comprehensive laboratory animal
monitoring system (Columbus Instruments) according to the
manufacturer’s instructions. Mice were measured for 24 h after
acclimated to the system for 16 to 20 h.
Open field test
The open field consisted of a box (50630620 cm) with normal
room illumination, which was divided into 10610 cm squares and
open at the top. Each mouse at 12 weeks of age was placed in the
centre of the box, and the number of squares entered (all four paws
inside the square) and rearings were counted for 0.5 min for 4 times
with an interval of 1 min for each time. The box was thoroughly
cleaned to remove odor cues before each mouse had been tested.
Rotarod test
The rotating rod was 3 cm in diameter and divided by flanges in
five compartments to allow testing of up to five mice simultaneously
[57]. The animals had to walk on the rotating rod at the indicated
speeds, and the time until the mouse fell from the rod or maintained
for 60 s was recorded. Mice at 8 months of age were tested from the
lowestspeedtogradually-increased speed, and wererestedforabout
40 min between each two tests with different speeds.
Western blot and coimmunoprecipitation
IRS2, SIRT1 and phosphotyrosine antibodies were from
Upstate; PTP1B antibody was from Novus Biologicals; acetylated-
lysine (AcK), ERK1/2 and phospho-ERK1/2 (Thr202/Tyr204)
antibodies were from Cell Signaling Technology; myc-tag antibody
was kindly provided by Dr. J. Zhou (Institute of Biochemistry and
Cell Biology, SIBS, CAS); GAPDH antibody was from Kangcheng
(Shanghai, China). Western blot and coimmunoprecipitation was
performed as previously described [58].
Real-time PCR
Total RNA from the collected tissues was isolated using TRIzol
reagent (Invitrogen). After treatment with RNase-free DNase I
(Takara), first-strand cDNA was synthesized with reverse transcrip-
tase and random hexamer primers (Invitrogen). Real-time PCR was
conducted using Power SYBR Green PCR Master Mix with the
ABI Prism 7900 sequence detection system (Applied Biosystems) as
described previously [59]. The primers used for real-time PCR are
mainly from PrimerBank (http://pga.mgh.harvard.edu/primer
bank), and listed in Table S1. 36B4 was measured for each sample
as the internal control. Three mice per group at 12 weeks of age
were used in real-time PCR except indicated.
Statistical analyses
Data are expressed as mean 6 SD except indicated. Statistical
analysis of differences was done via unpaired two-tailed Student’s
t test except indicated. Two-way analysis of variance (ANOVA)
followed by Bonferroni’s test was performed using GraphPad
Prism 5.0 (GraphPad Software). P,0.05 was considered statisti-
cally significant.
Supporting Information
Figure S1 Male bitransgenic mice exhibit increased fat
accumulation. (A) Body weights of male bitransgenic mice were
not changed compared with littermate controls (n=6–8 for each
group). (B–C) Fat mass and fat content increased in male
bitransgenic mice when compared with littermate controls
(n=6–8 for each group). (D) Lean contents decreased in male
bitransgenic mice when compared with littermate controls (n=6–8
for each group). (E) Fasting serum levels of triglyceride (TG), total
cholesterol (TC), high-density lipoprotein cholesterol (HDLc) and
low-density lipoprotein cholesterol (LDLc) were measured at 3
months of age (n=6–7 for each group). * P,0.05, ** P,0.01
versus littermate controls.
(TIF)
Figure S2 Glucose tolerance is moderately impaired in
male bitransgenic mice. (A) Glucose tolerance was impaired
in 5-month-old male bitransgenic mice as determined by glucose
tolerance test (n=6–7 for each group). Two-way ANOVA
indicated that the curves for glucose tolerance are significantly
different, P=0.0376. (B) The area under the curve (AUC) of the
glucose tolerance test in (A) was similar. (C) 5-month-old male
transgenic mice have similar insulin sensitivity as determined by
insulin tolerance test (n=6–7 for each group). (D) The AUC of the
insulin tolerance test in (C) did not change in male transgenic mice
(n=6–7 for each group). (E) Fasting serum insulin was measured at
3 months of age (n=6–7 for each group). * P,0.05 versus
littermate controls.
(TIF)
Figure S3 Male bitransgenic mice show similar physi-
cal activity, oxygen consumption, body temperature and
decreased food intake. (A) Food intake of male bitransgenic
mice decreased when compared with littermate controls (n=5 for
each group). (B) Physical activity did not change in male
bitransgenic mice at 16 weeks of age, measured through a 12-h
light/dark cycle (n=5 for each group). Physical activity was
presented as mean 6 SEM. (C) Oxygen consumption did not
change in male bitransgenic mice (n=4–5 for each group). (D)
Body temperature did not change in male bitransgenic mice at 8
months of age (n=5 for each group). * P,0.05 versus littermate
controls.
(TIF)
Figure S4 Male bitransgenic mice show decreased
motor behavior by open field and rotarod performance
tests. (A) Crossed squares in the open field test did not change in
male bitransgenic mice (n=5 for each group). Two-way ANOVA
showed no significant difference between groups. (B) Male
bitransgenic mice had similar number of rearings in the open
field test (n=5 for each group). Two-way ANOVA showed no
significant difference between groups. (C) Rotarod performance
on the first day was decreased in male bitransgenic mice (n=5 for
each group). ** P,0.01 versus littermate controls by two-way
ANOVA. Two-way ANOVA showed significant difference
between curves, P=0.0225. (D) Rotarod performance on the
second day was slightly decreased in male bitransgenic mice (n=5
for each group). * P,0.05, ** P,0.01 versus littermate controls by
two-way ANOVA.
(TIF)
Figure S5 Leptin is upregulated in female bitransgenic
mice, and the expression of PTP1B, Lepr, Socs3 and
some feeding related neuropeptides is not changed in
striatum or hypothalamus. (A) The mRNA levels of PTP1B
in the striatum (n=3 for each group) and hypothalamus (n=6–7
for each group) of female bitransgenic mice were not changed. (B)
The protein levels of PTP1B in the striatum and hypothalamus of
female bitransgenic mice were not changed (n=3 for each group).
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the relative PTP1B protein levels corresponding to (B). (D) The
mRNA levels of leptin in WAT (n=3 for each group) and fed
serum leptin levels (n=10 for each group) of female bitransgenic
mice were significantly elevated. (E) The mRNA levels of Lepr,
Socs3 in the striatum (n=3 for each group) and hypothalamus
(n=6–7 for each group) of female bitransgenic mice were not
changed. (F) The mRNA levels of some feeding related
neuropeptides in hypothalamus of female bitransgenic mice were
not changed (n=6–7 for each group). * P,0.05, ** P,0.01 versus
littermate controls.
(TIF)
Figure S6 The mRNA levels of Pgc1a related genes in
the striatum of female mice, the mouse snout-anus
length and male serum T3, T4 levels. (A) The expression of
Pgc1a and its related genes did not alter in the striatum of female
bitransgenic mice (n=3 for each group). (B) The mouse snout-anus
length was similar between bitransgenic mice and controls (n=6–7
for each group). (C) Serum T3 and T4 levels were decreased in
male bitransgenic mice (n=10–11 for each group). * P,0.05
versus littermate controls.
(TIF)
Figure S7 The Sirt1 mRNA levels in different brain
regions under feeding, fasting and refeeding conditions.
The Sirt1 mRNA levels of olfactory bulb, cerebral cortex,
striatum, hippocampus, hypothalamus, thalamus and hindbrain
from 8-week-old female mice fed ad libitum, fasted for 24 h, or
fasted for 24 h and refed for 24 h were analyzed by real-time PCR
(n=5–7). * P,0.05 versus fed ad libitum.
(TIF)
Table S1 Primers used in real-time PCR.
(DOC)
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